Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 8/20 | 0.50 |
| ▸ | PNP | P00491 | 3/20 | 0.47 |
| ▸ | TK1 | P04183 | 2/20 | 0.47 |
| ▸ | STING1 | Q86WV6 | 5/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EDNRA | P25101 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | VCP | P55072 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL986800 | 0.88 | XDH (0.60) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL15005119 | 0.86 | XDH (0.59) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL1825531 | 0.84 | XDH (0.51) | XDHPNPTK1STING1BLM | |
| SCHEMBL28886471 | 0.84 | ADORA2A (0.40) | XDHSTING1BLMMEN1ALDH1A1 | |
| SCHEMBL523465 | 0.80 | XDH (0.47) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL580610 | 0.79 | ADORA2A (0.64) | — | |
| SCHEMBL27773184 | 0.79 | ADORA2A (0.43) | STING1 | |
| SCHEMBL28413958 | 0.78 | ADORA2A (0.62) | — | |
| SCHEMBL72147 | 0.77 | XDH (0.50) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL556881 | 0.76 | XDH (0.50) | XDHPNPTK1BLMUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115287272-A | Novel dye decoloring method for clone and recombinase of DyP-type peroxidase gene | 浙江省农业科学院 | 2022-11-04 | — | — | CN | claimed |
| US-20090305284-A1 | Methods for Identifying Risk of Breast Cancer and Treatments Thereof | SEQUENOM, INC. (US) | 2009-12-10 | — | — | US | claimed |
| US-6153404-A | REGULATORY SEQUENCE LINKED TO SEQUENCE CODING FOR A HETEROLOGOUS POLYPEPTIDE; FOR CONTROLLED/INDUCIBLE GENE EXPRESSION IN RECOMBINANT SYSTEM | INSTITUT PASTEUR (FR) | 2000-11-28 | — | — | US | claimed |
| US-5780617-A | PHOSPHORYLATION OF A PHOSPHATIDES WITH A NUCLEOTIDES | NEXSTAR PHARMACEUTICALS, INC. (US) | 1998-07-14 | — | — | US | claimed |
| EP-0594776-A1 | PLASMID REPLICATION ORIGIN INCREASING THE NUMBER OF COPIES OF THE PLASMID CONTAINING SAID ORIGIN | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 1994-05-04 | — | — | EP | claimed |
| WO-1993001293-A1 | PLASMID REPLICATION ORIGIN INCREASING THE NUMBER OF COPIES OF THE PLASMID CONTAINING SAID ORIGIN | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 1993-01-21 | — | — | WO | claimed |
| US-20240117346-A1 | MODIFIED HETERO NUCLEIC ACIDS | NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (JP) | 2024-04-11 | — | — | US | disclosed |
| CN-117487804-A | Assembled pRNA nano delivery body for single base site-directed editing of mRNA and application of assembled pRNA nano delivery body in gene therapy | 福建军生精准医疗科技有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-116515963-A | TJ-ARMS method for detecting base mutation and methylation analysis | 汕头大学 | 2023-08-01 | — | — | CN | disclosed |
| WO-2023131727-A1 | C-NUCLEOSIDE MONOPHOSPHATE SYNTHESIS | UAB BIOMATTER DESIGNS (LT) | 2023-07-13 | — | — | WO | disclosed |
| US-20230027885-A1 | TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY | YALE UNIVERSITY (US) | 2023-01-26 | — | — | US | disclosed |
| US-20230025756-A1 | INDUCTION OF REGULATORY B CELLS FOR THE TREATMENT OF IMMUNE-MEDIATED DISEASES | CHILDRESS, SUSAN BOACKLE | 2023-01-26 | — | — | US | disclosed |
| CN-115491418-A | Second-generation sequencing panel of target genes with congenital incomplete lens dislocation and sequencing method | 复旦大学附属眼耳鼻喉科医院 | 2022-12-20 | — | — | CN | disclosed |
| WO-1993001293-A1 | PLASMID REPLICATION ORIGIN INCREASING THE NUMBER OF COPIES OF THE PLASMID CONTAINING SAID ORIGIN | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 1993-01-21 | — | — | WO | disclosed |
| US-5047519-A | Alkynylamino-nucleotides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0159264-B1 | ANTIVIRAL COMPOUNDS | MERCK & CO. INC. (US) | 1991-07-24 | — | — | EP | disclosed |
| US-4980460-A | Protected nucleosides which permit more efficient oligonucleotide syntheses | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1990-12-25 | — | — | US | disclosed |
| US-4617304-A | VIRICIDE; HERPES | MERCK & CO., INC. (US) | 1986-10-14 | — | — | US | disclosed |
| EP-0159264-A2 | Antiviral compounds | MERCK & CO. INC. (US) | 1985-10-23 | — | — | EP | disclosed |
| US-3947605-A | Process for preparing high yields of single cell products having reduced purine content and high nutritive value | STANDARD OIL COMPANY (US) | 1976-03-30 | — | — | US | disclosed |